Biotech Clinical Development
Cisema provides tailored clinical development and regulatory services for companies advancing next-generation therapies including Cell and Gene Therapies, CAR-T, monoclonal antibodies, peptides, and RNA-based platforms. With over 20 years of experience across China and the Asia Pacific region, we support biotech innovators through clinical strategy, regulatory planning, and post-market surveillance.
Our bilingual teams across Asia align development plans with regional regulatory frameworks to help you manage risk, secure approvals, and ensure long-term compliance. Whether you are an early-stage biotech or scaling for commercialization, Cisema supports your journey with clarity, precision and cross-border insights.
Biotech Clinical Development Services
Strategic Clinical Development Planning
We design development strategies that are tailored to the scientific and regulatory demands of advanced biotech therapies, while aligning with the timelines and milestones critical to fundraising, licensing, and market entry across APAC.
Regulatory GAP Analysis & Fast-Track Access
Innovative biotech products face evolving and market-specific regulatory expectations. Cisema provides strategic insight to ensure your documentation meets APAC authority standards and supports global expansion.
Submission Preparation & Authority Engagement
Cisema serves as your in-region regulatory representative to coordinate submissions and facilitate interactions with health authorities across APAC.
Post-Market Clinical Support & Real-World Data
We support post-approval evidence generation to maintain compliance and demonstrate long-term product value.
Expertise in Advanced Biotech Modalities
Our services support the clinical development of cutting-edge therapies:
Request a Proposal from Our Biotech Team
Let Cisema help turn your plans into reality.
Why Work with Cisema?
Local expertise with global reach
Our bilingual teams bridge international quality standards with local regulations
Proven track record
Over 20 years supporting market approvals and compliance in China and Asia Pacific
End-to-end solutions
From system setup to post-market surveillance, we ensure quality management and regulatory compliance throughout the product lifecycle
Industry breadth
Cross-sector expertise in life sciences, food, veterinary, consumer and industrial goods
Explore Related Services
Health Economics & Market Access
Accelerate access across China and Asia Pacific with confidence. Our market access consulting experts help life sciences companies optimize patient access, navigate pricing and reimbursement challenges, and enable commercial success through real world evidence, health economics, and tailored access strategies.
Regulatory Affairs
Navigate regulatory complexity across China and Asia Pacific with confidence. Our regulatory affairs consulting experts support biotech companies with strategic planning, compliant submissions, and local representation to accelerate approvals and ensure market readiness.
Pharmacovigilance
Ensure drug safety and regulatory compliance across China and Asia Pacific with confidence. Our pharmacovigilance consulting experts support life sciences companies in managing risks, meeting evolving safety requirements, and maintaining market authorization through end-to-end PV solutions tailored to local regulations.
Quality Management & Compliance
Ensure regulatory excellence across China and Asia Pacific with confidence. Our quality management and compliance experts help life sciences companies strengthen GxP systems, streamline audits, and maintain inspection readiness to safeguard market access and operational performance.
